
Founded in 1979 and headquartered in Dublin, Ohio, Cardinal Health, Inc. (CAH) is a leading distributor of pharmaceuticals as well as a global manufacturer and distributor of medical and laboratory products. Valued at a market cap of $23.5 billion, the company also offers performance and data solutions to healthcare facilities, aiming to improve operational efficiency and patient outcomes.
Shares of this healthcare distributor have significantly underperformed the broader market over the past 52 weeks. CAH stock has surged 13.5% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 28.9%. In 2024, shares of Cardinal Health are down 4.4%, compared to the SPX's 11.2% gains on a YTD basis.